大剂量静脉注射免疫球蛋白治疗自发性肝素诱导性血小板减少症综合征
自发性肝素诱导性血小板减少症(HIT)综合征是一种自身免疫性HIT疾病,表现为血小板减少、血栓形成和HIT抗体阳性,但无近期肝素暴露。一例52岁女性在全膝关节置换术后12天出现肠系膜上静脉血栓和血小板减少(63×10^9/L),接受大剂量静脉注射免疫球蛋白(IVIg)1g/kg连续2天后,血小板计数从21×10^9/L升至137×10^9/L,2天后升至200×10^9/L;肝素非依赖性血清诱导的5-羟色胺释放从91%降至14%,后反弹至49%,但血小板计数保持正常。观察结果支持大剂量IVIg对治疗自身免疫性HIT疾病(包括自发性HIT综合征)有效的观点。
要点
- 自发性HIT综合征表现为血小板减少、血栓形成和HIT抗体阳性,无近期肝素暴露。
- 全膝关节置换术后可发生自发性HIT综合征,肠系膜静脉血栓是罕见表现。
- 大剂量IVIg(1g/kg连续2天)可快速纠正血小板减少,抑制肝素非依赖性血小板活化。
核心结论
- 观察结果支持大剂量IVIg对治疗自身免疫性HIT疾病(包括自发性HIT综合征)有效的观点。
研究设计与样本
- 病例报告:一例52岁女性在全膝关节置换术后12天发生自发性HIT综合征。
主要发现
- 患者术后12天出现消化道出血(肠系膜上静脉血栓),血小板计数63×10^9/L。
- 大剂量IVIg 1g/kg连续2天后,血小板计数从IVIg前最低值21×10^9/L升至IVIg后137×10^9/L,2天后升至200×10^9/L。
- 肝素非依赖性血清诱导的5-羟色胺释放从IVIg前91%降至IVIg后14%,后反弹至49%,但血小板计数保持正常。
关键数值与推荐
- 大剂量IVIg用法:1g/kg,连续2天。
临床怎么用
- 作者认为大剂量IVIg对治疗自身免疫性HIT疾病(包括自发性HIT综合征)有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials Spontaneous HIT syndrome clinically/serologically resembles HIT but without proximate heparin. Rarely, spontaneous HIT syndrome complicates total knee arthroplasty surgery. Mesenteric vein thrombosis is a rare presentation of spontaneous HIT syndrome. IVIg rapidly corrects thrombocytopenia by inhibiting heparin-independent platelet activation. SUMMARY: Spontaneous heparin-induced thrombocytopenia (HIT) syndrome is an autoimmune HIT (aHIT) disorder characterized by thrombocytopenia, thrombosis, and HIT antibodies despite no proximate heparin exposure. For unknown reasons, many cases occur after total knee arthroplasty. A 52-year-old woman presented 12 days posttotal knee replacement (aspirin thromboprophylaxis) with gastrointestinal bleeding (superior mesenteric vein thrombosis); the platelet count was 63 × 109 L-1 . After bowel resection and a brief course of heparin, treatment was changed to argatroban followed by fondaparinux. In addition, high-dose intravenous immunoglobulin (IVIg), 1 g kg-1 on 2 consecutive days, resulted in abrupt platelet count rise from 21 (nadir) pre-IVIg to 137 (post-IVIg), and 2 days later to 200 × 109 L-1 . Heparin-independent serum-induced serotonin-release abruptly decreased from 91% (pre-IVIg) to 14% (post-IVIg); although serotonin-release later rebounded to 49%, the patient's platelet counts remained normal. Our observations support the emerging concept that high-dose IVIg is effective for treating aHIT disorders, including spontaneous HIT syndrome.
引用
- Mohanty E, Nazir S, Sheppard JI, et al. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome. J Thromb Haemost. 2019. PMID: 30773806. doi:10.1111/jth.14411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。